Search
Ceftezole
go.drugbank.com/drugs/DB13821InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCefatrizine
go.drugbank.com/drugs/DB13266InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseHyperforin
go.drugbank.com/drugs/DB01892InvestigationalNutraceuticalHyperforin is a phytochemical generated by the plants of the Hypericum family.
Tagorizine
go.drugbank.com/drugs/DB20098ExperimentalTagorizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Tagorizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Tagorizine has a monoisotopic molecular weight of 468.29 Da.
Trelnarizine
go.drugbank.com/drugs/DB21183ExperimentalTrelnarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Trelnarizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Trelnarizine has a monoisotopic molecular weight of 464.23 Da.
Belarizine
go.drugbank.com/drugs/DB20540ExperimentalBelarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Belarizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Belarizine has a monoisotopic molecular weight of 358.2 Da.
Itolizumab
go.drugbank.com/drugs/DB16207InvestigationalItolizumab is under investigation in clinical trial NCT04605926 (A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19).
Zastumotide
go.drugbank.com/drugs/DB14926InvestigationalZastumotide is a recombinant MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (MAGE-A3 ASCI) also known as astuprotimut-R. … It is under investigation in clinical trial NCT00257738 (0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck).
BB 21217
go.drugbank.com/drugs/DB17373Investigational21217 is an anti-BCMA CAR T cell therapy that uses the same CAR molecule as [idecabtagene vicleucel] (bb2121), but adds the PI3K inhibitor bb007 during ex vivo culture to enrich the drug product (DP) for
RGX-501
go.drugbank.com/drugs/DB17639InvestigationalIt is being investigated for the treatment of homozygous familial hypercholesterolemia.[L46696] … RGX-501 is an adeno-associated virus vector 8 (AAV8)-mediated gene therapy that delivers a functional copy of the human low-density lipoprotein receptor (LDLR) gene to liver cells.